Global WholeHealth Partners Corporation
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Edgar B. Gonzalez
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Address
- 1402 North El Camino Real San Clemente CA United States of America 92672
- IPO Date
- Apr 9, 2015
- CIK
- 0001598308
- Website
- gwhpcorp.com
- Similar Companies
- Business
- Global WholeHealth Partners Corporation (GWHP) develops, manufactures, and distributes advanced wound care solutions and rapid diagnostic tests for point-of-care and over-the-counter use worldwide. The company offers SilverStream Solution, an OTC and prescription wound management product that accelerates healing for chronic, infected, and non-healing wounds, burns, and surgical sites through superior biofilm destruction and infection control; a portfolio of approximately 125 in-vitro diagnostic (IVD) test kits using whole blood, serum, or plasma for rapid disease detection in under 90 minutes, including tests for colorectal cancer, pregnancy, ovulation, glucose, drugs of abuse (such as Strep A strips and cassettes, H-Pylori, gonorrhea, tricyclic antidepressants, ecstasy, and phencyclidine), infectious diseases (Ebola, Zika, dengue, malaria, influenza, tuberculosis, coronaviruses, and yellow fever); and specialized professional tests across categories like diagnostic tests, drug tests, and infectious disease panels serving hospitals, clinics, physicians' offices, nursing homes, home health agencies, and consumers. Founded in 2013 and headquartered in San Clemente, California, GWHP operates primarily in the United States with international supply capabilities targeting healthcare professionals and patients in need of accelerated diagnostics and wound healing technologies. Recent developments include a 2022 funding agreement with EMC2 Funding for up to $100 million in equity over 36 months to support growth and retail launches of five OTC products including pregnancy, ovulation, drug, glucose, and colorectal cancer tests via platforms like Walmart and Amazon; an ongoing emphasis on SilverStream portfolio expansion for human and veterinary applications; and maintenance of over 70 FDA-approved products amid strategic focus on epidemic and vector-borne disease testing.
Head to Head Comparison: Fonar (NASDAQ:FONR) and Global Wholehealth Partners (OTCMKTS:GWHP)
Global WholeHealth Partners Corp. (OTC: GWHP), is Approved to Sell Through Walmart, Amazon, eBay and Shopify as Stated in the 8K Filing 08/03/2021; Global's Newly Designed Tests Are Now Ready for the Launch into the Retail Marketplace
Global WholeHealth Partners Corp. (OTC: GWHP) Has Been Approved to Sell Its Products Through Walmart and Amazon as Stated in the 8K Filing 08/03/2021; Global's Newly Designed Tests Are Now Ready for the Launch Into the Retail Marketplace
Global WholeHealth Partners Corp (OTC: GWHP) Partners With Pan Probe Biotech and AvantGen to Develop the Newest COVID19 Antigen Test on the Market; 8k Filed on 09/21/2021
FDA Approves First COVID-19 Vaccine Which Can Be Distributed by Global WholeHealth Partners Corp (OTC: GWHP) as US Anticipates Considerable Uptick in Vaccination Rates, as Stated in 8K Filing 06/15/21
Global WholeHealth Partners Corp. (OTC:GWHP) Gains Approval in a Deal to Sell Through Ebay's $100 Billion Online Marketplace as Stated in 8K Filing 08/05/21
Global WholeHealth Partners Corp.'s (OTC: GWHP) Antibody IgG/IgM and Antigen Tests That They Offer Are Capable of Detecting the DELTA B.1.617.2, United Kingdom (B.1.1.7), South Africa (B.1.351), and Brazil (P.1) of COVID 19 SARS 2
Global WholeHealth Partners, Corp. (OTC: GWHP) Confirms They Offer Antibody and Antigen Test Kits That Detect Fast Spreading Mutated COVID-19 Strains, DELTA (B.1.617.2), (UK (B.1.1.7), S. Africa (B.
Global WholeHealth Partners Corp (OTC:GWHP) Gives an Update on Salud Previa of Tijuana, MX; Salud Previa is Located at Av. Paseo del Rio 6672 N2 L204 3ra Etapa Rio, Tijuana, Baja California, www.SaludPrevia.com
Global WholeHealth Partners Corp (OTC:GWHP) Ships Its First Shipment of Over 20,000 Tests to Salud Previa of Tijuana, MX; Salud Previa Has Indicated That It Plans on Purchasing More Than 500,000 Tests Over the Next 12 Months
Findit Features Members Global WholeHealth Partners, ClassWorx and OTC Tip Reporter Who Utilize Findit Marketing Campaigns To Improve Online Exposure
Global WholeHealth Partners Corp (GWHP-OTC) Acquires Rights to Distribute & Sell a 2nd COVID-19 Vaccine - The Pfizer-BioNTech
Global WholeHealth Partners Corp. (GWHP-OTC) Acquires Rights to Distribute & Sell Johnson & Johnson COVID-19 Vaccine
Global WholeHealth Partners Corp (GWHP-OTC) has Signed an Agreement With Dr. Vu Le to be the Medical Director for the CLIA WAIVED Mobile Laboratory
Global WholeHealth Partners Corp (OTC: GWHP) and AAJ has Partnered Together and Agreed to Open a Facility in the Philippines Under the Name Global Wholehealth Philippines, as Filed in 8k on May 21, 2021
Global is Going Mobile; Global WholeHealth Partners Corp (GWHP-OTC) has Signed an Agreement With Dr. Vu Le to be the Medical Director for the CLIA WAIVED Mobile Laboratory
Alzheimer's Disease is the leading cause of Dementia; Alzheimer's Diagnostics Attained by Global WholeHealth Partners, Corp (OTC: GWHP) as a Leading Researcher
Update on Global WholeHealth Partners Corp (OTC:GWHP) and Nunzia Pharmaceutical Inc. Agreement for Sales and Marketing; First Purchase Order is for $25,000 From Nunzia to Global
ClassWorx Announces Interview with Global WholeHealth Partners Corporation (GWHP) with CEO Charles Strongo, Now Live on YouTube
Global WholeHealth Partners Corp. (OTC:GWHP) Partners with Nunzia Pharmaceutical Inc., Opening New Avenues of Revenue and Products for Global